249 related articles for article (PubMed ID: 12476796)
1. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
Lefebvre P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
[TBL] [Abstract][Full Text] [Related]
2. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
3. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
Ahuja HS; Szanto A; Nagy L; Davies PJ
J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
[TBL] [Abstract][Full Text] [Related]
4. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
5. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
6. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
Lammi J; Perlmann T; Aarnisalo P
Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
[TBL] [Abstract][Full Text] [Related]
7. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification.
Pijnappel WW; Hendriks HF; Folkers GE; van den Brink CE; Dekker EJ; Edelenbosch C; van der Saag PT; Durston AJ
Nature; 1993 Nov; 366(6453):340-4. PubMed ID: 8247127
[TBL] [Abstract][Full Text] [Related]
8. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
Toma S; Isnardi L; Riccardi L; Bollag W
Anticancer Res; 1998; 18(2A):935-42. PubMed ID: 9615744
[TBL] [Abstract][Full Text] [Related]
10. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation.
Fanjul A; Dawson MI; Hobbs PD; Jong L; Cameron JF; Harlev E; Graupner G; Lu XP; Pfahl M
Nature; 1994 Nov; 372(6501):107-11. PubMed ID: 7969403
[TBL] [Abstract][Full Text] [Related]
11. Nuclear retinoid receptors and the transcription of retinoid-target genes.
Bastien J; Rochette-Egly C
Gene; 2004 Mar; 328():1-16. PubMed ID: 15019979
[TBL] [Abstract][Full Text] [Related]
12. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H
J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523
[TBL] [Abstract][Full Text] [Related]
13. Regulation of lipid and lipoprotein metabolism by retinoids.
Staels B
J Am Acad Dermatol; 2001 Nov; 45(5):S158-67. PubMed ID: 11606948
[TBL] [Abstract][Full Text] [Related]
14. A decade of molecular biology of retinoic acid receptors.
Chambon P
FASEB J; 1996 Jul; 10(9):940-54. PubMed ID: 8801176
[TBL] [Abstract][Full Text] [Related]
15. Action mechanism of retinoid-synergistic dibenzodiazepines.
Umemiya H; Kagechika H; Fukasawa H; Kawachi E; Ebisawa M; Hashimoto Y; Eisenmann G; Erb C; Pornon A; Chambon P; Gronemeyer H; Shudo K
Biochem Biophys Res Commun; 1997 Apr; 233(1):121-5. PubMed ID: 9144408
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activities of retinoic acid receptors.
Lefebvre P; Martin PJ; Flajollet S; Dedieu S; Billaut X; Lefebvre B
Vitam Horm; 2005; 70():199-264. PubMed ID: 15727806
[TBL] [Abstract][Full Text] [Related]
17. RXR: from partnership to leadership in metabolic regulations.
Desvergne B
Vitam Horm; 2007; 75():1-32. PubMed ID: 17368310
[TBL] [Abstract][Full Text] [Related]
18. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
[TBL] [Abstract][Full Text] [Related]
19. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.
Jiang SY; Shen SR; Shyu RY; Yu JC; Harn HJ; Yeh MY; Lee MM; Chang YC
Br J Cancer; 1999 Apr; 80(1-2):206-14. PubMed ID: 10389997
[TBL] [Abstract][Full Text] [Related]
20. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
LeMotte PK; Keidel S; Apfel CM
Biochim Biophys Acta; 1996 Mar; 1289(2):298-304. PubMed ID: 8600988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
